{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:53:44Z","timestamp":1768553624941,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajo.2025.05.030","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:05:24Z","timestamp":1748430324000},"page":"335-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Relationship of Hydroxychloroquine Retinopathy Progression to Stage at Cessation of Therapy"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0442-8122","authenticated-orcid":false,"given":"David J.","family":"Browning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0127-2299","authenticated-orcid":false,"given":"Donnie R.","family":"Koonce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Mentreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Punjabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2025.05.030_bib0001","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaophthalmol.2014.1099","article-title":"Effect of disease stage on progression of hydroxychloroquine retinopathy","volume":"132","author":"Marmor","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.030_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/IAE.0000000000002408","article-title":"Sequential changes in hydroxychloroquine retinopathy up to 20 years after stopping the drug: implications for mild versus severe toxicity","volume":"39","author":"Pham","year":"2019","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ajo.2025.05.030_bib0003","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2013.4244","article-title":"Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging","volume":"131","author":"Mititelu","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.05.030_bib0004","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/IAE.0000000000001217","article-title":"Loss of external limiting membrane integrity predicts progression of hydroxychloroquine retinal toxicity after drug discontinuation","volume":"36","author":"Scarinci","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2025.05.030_bib0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/OPTH.S66527","article-title":"Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy","volume":"8","author":"Browning","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.030_bib0006","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2147\/OPTH.S82398","article-title":"Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy","volume":"9","author":"Browning","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.030_bib0007","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/OPTH.S87850","article-title":"Scotoma analysis of 10-2 visual field testing with a red target in screening for hydroxychloroquine retinopathy","volume":"9","author":"Browning","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.030_bib0008","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.ophtha.2015.01.014","article-title":"Pericentral hydroxychloroquine retinopathy in Korean patients","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2025.05.030_bib0009","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.122.7.973","article-title":"Multifocal electroretinographic evaluation of long-term hydroxychloroquine users","volume":"122","author":"Maturi","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.030_bib0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/OPTH.S27731","article-title":"Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study","volume":"6","author":"Farrell","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.05.030_bib0011","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","article-title":"Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography","volume":"143","author":"Lyons","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.030_bib0012","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00417-011-1753-2","article-title":"Comparison of different screening methods for chloroquine\/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography","volume":"250","author":"Missner","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.030_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10633-008-9130-0","article-title":"Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: review of mfERG ring ratios in Plaquenil toxicity","volume":"118","author":"Lyons","year":"2009","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.030_bib0014","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ajo.2012.09.025","article-title":"Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice","volume":"155","author":"Browning","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.05.030_bib0015","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.ophtha.2006.10.055","article-title":"Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema","volume":"114","author":"Krzystolik","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2025.05.030_bib0016","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaophthalmol.2014.1698","article-title":"Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema","volume":"132","author":"Bressler","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.030_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcjo.2019.05.013","article-title":"Effect of stopping hydroxychloroquine therapy on the multifocal electroretinogram in patients with rheumatic disorders","volume":"55","author":"Adamptey","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.030_bib0018","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1016\/j.ajo.2016.03.044","article-title":"The prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing both","volume":"166","author":"Browning","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.05.030_bib0019","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.05.030_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archophthalmol.2010.321","article-title":"Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy","volume":"129","author":"Michaelides","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2025.05.030_bib0021","series-title":"Hydroxychloroquine and Chloroquine Retinopathy","author":"Browning","year":"2014"},{"issue":"3","key":"10.1016\/j.ajo.2025.05.030_bib0022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IAE.0000000000002437","article-title":"Longitudinal changes in eyes with hydroxychloroquine retinal toxicity","volume":"39","author":"Allahdina","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2025.05.030_bib0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-016-0042-y","article-title":"Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation","volume":"2","author":"Lally","year":"2016","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.ajo.2025.05.030_bib0024","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2147\/OPTH.S66528","article-title":"Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users","volume":"8","author":"Browning","year":"2014","journal-title":"Clin Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:19:52Z","timestamp":1754918392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"alternative-id":["S0002939425002661"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.030","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Relationship of Hydroxychloroquine Retinopathy Progression to Stage at Cessation of Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}